US Patent Number

10,544,112

Publication Date

1-28-2020

Abstract

The invention relates to novel ebsulfur analogues and novel pharmaceutical compositions comprising ebsulfur analogues. The invention also relates to novel methods of treating infections caused by fungal species comprising administration of ebselen, ebsulfur, and ebsulfur analogues.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

15/940,544

Filing Date

3-29-2018

Share

COinS